NCT04747912 2026-03-30Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)University of ChicagoPhase 2 Suspended25 enrolled
NCT04661137 2026-02-10A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple MyelomaHackensack Meridian HealthPhase 2 Suspended96 enrolled